ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Washington, DC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Recurrence
Adenocarcinoma
Breast Cancer

Prostate Cancer trials near Washington, DC, USA:

Nivolumab in Biochemically Recurrent dMMR Prostate Cancer

predicted neoantigen load. Prevalence estimates of MMR deficiency across solid tumor types range from 1% to 20% depending on the type of ma ...

Enrolling
Recurrent Prostate Cancer
Prostate Cancer
Drug: Nivolumab

Phase 2

Johns Hopkins Medicine
Johns Hopkins Medicine

Baltimore, Maryland, United States

Asymptomatic patients with metastatic castrate resistant prostate cancer (mCRPC) without pain due to prostate cancer...

Enrolling
Prostate Cancer
Drug: Enzalutamide
Drug: Luteinizing hormone-releasing hormone (LHRH) analogue

Phase 2

Johns Hopkins Medicine
Johns Hopkins Medicine

Baltimore, Maryland, United States

The purpose of this study is to evaluate the effectiveness of CAN-2409 immunotherapy in patients undergoing active surveillance for localized prostate...

Active, not recruiting
Prostate Cancer
Biological: placebo
Drug: valacyclovir

Phase 2

Candel Therapeutics

Bethesda, Maryland, United States and 22 other locations

This was a randomized study to evaluate the risk of major adverse cardiovascular events (MACE) for relugolix compared with leuprolide acetate. Enroll...

Active, not recruiting
Prostate Cancer
Drug: Leuprolide Acetate
Drug: Relugolix

Phase 3

Sumitomo Pharma
Sumitomo Pharma

Washington, District of Columbia, United States and 107 other locations

The purpose of this study is to learn whether PYLARIFY PET imaging (study scan) can safely and accurately detect the presence or absence of prostate...

Enrolling
Prostate Cancer
Drug: Piflufolastat F 18 Intravenous Solution [PYLARIFY]

Phase 4

Lantheus Medical Imaging
Lantheus Medical Imaging

Baltimore, Maryland, United States and 9 other locations

Prostate cancer is usually treated by reducing the amount of testosterone in the body. PRL-02 depot is a potential treatment for me ...

Enrolling
Prostate Cancer
mCSPC
Drug: prednisone
Drug: PRL-02 injection

Phase 1

Astellas
Astellas

Towson, Maryland, United States and 13 other locations

A Phase 1/2 study to evaluate the safety and efficacy of ARV-766 given by mouth alone or in combination with abiraterone in men with metastatic prostate...

Enrolling
Prostate Cancer Metastatic
Drug: ARV-766 + Abiraterone Part C&D
Drug: ARV-766 Part A&B

Phase 1, Phase 2

Arvinas
Arvinas

Washington, District of Columbia, United States and 22 other locations

inhibitor, in Veterans with metastatic castration-resistant prostate cancer (mCRPC) characterized by either mismatch repair deficie...

Enrolling
Metastatic Castration Resistant Prostate Cancer
Drug: Pembrolizumab

Phase 2

VA Office of Research and Development
VA Office of Research and Development

Washington, District of Columbia, United States and 11 other locations

This study evaluates the efficacy, anti-tumor effect, and immunogenicity of neoadjuvant enoblituzumab given before radical prostatectomy. Pa...

Enrolling
Prostate Cancer
Drug: Enoblituzumab
Other: Standard of Care

Phase 2

Johns Hopkins Medicine
Johns Hopkins Medicine

Baltimore, Maryland, United States

radiation therapy for patients with intermediate-high risk localized prostate cancer. ProstAtak kills tumor cells and stim...

Active, not recruiting
Prostate Cancer
Biological: Placebo + valacyclovir
Biological: Aglatimagene besadenovec + valacyclovir

Phase 3

Candel Therapeutics

Washington, District of Columbia, United States and 72 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems